Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nanoliposomal Irinotecan”

144 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 144 results

Early research (Phase 1)Looking for participantsNCT05277766
What this trial is testing

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+5 more
University Hospital, Ghent 45
Testing effectiveness (Phase 2)UnknownNCT03528785
What this trial is testing

Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Centro Ricerche Cliniche di Verona 67
Testing effectiveness (Phase 2)Looking for participantsNCT04150640
What this trial is testing

Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma

Who this might be right for
Esophageal AdenocarcinomaGastric Adenocarcinoma
University of Wisconsin, Madison 52
Testing effectiveness (Phase 2)UnknownNCT04569916
What this trial is testing

Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors

Who this might be right for
Solid Tumor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06993025
What this trial is testing

Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies

Who this might be right for
Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06697366
What this trial is testing

Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric Cancer

Who this might be right for
Gastric Cancer
Ruijin Hospital 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06375642
What this trial is testing

A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04005339
What this trial is testing

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Georgetown University 48
Testing effectiveness (Phase 2)Looking for participantsNCT06739928
What this trial is testing

Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Guangzhou Institute of Respiratory Disease 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07099794
What this trial is testing

A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen

Who this might be right for
Biliary Tract Cancer (BTC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07521605
What this trial is testing

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

Who this might be right for
Rectal Cancer Patients
Guangdong Provincial People's Hospital 44
Testing effectiveness (Phase 2)Looking for participantsNCT06662006
What this trial is testing

Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients

Who this might be right for
Advanced Metastatic Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 56
Early research (Phase 1)Study completedNCT02631733
What this trial is testing

Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors

Who this might be right for
Malignant Solid Neoplasm
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT04984174
What this trial is testing

Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan

Who this might be right for
Pancreatic Cancer
National Cancer Center, Korea 14,760
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07051785
What this trial is testing

Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer (CRC)
Liu Huang 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT03337087
What this trial is testing

Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

Who this might be right for
Metastatic Biliary Tract CarcinomaMetastatic Colorectal CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+6 more
Academic and Community Cancer Research United 18
Not applicableNot Yet RecruitingNCT06462105
What this trial is testing

Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Zhou Chengzhi 60
Testing effectiveness (Phase 2)Study completedNCT04727853
What this trial is testing

Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer (SCLC)
CSPC Ouyi Pharmaceutical Co., Ltd. 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06332950
What this trial is testing

Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Baohui Han 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06434090
What this trial is testing

Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 74
Load More Results